agilon health (AGL) TD Cowen 46th Annual Health Care Conference summary

Financial performance and cost trends

• Year-end cost trend reached 6.5%, with Q3 inpatient cases driving a spike to 7.2% and ongoing elevated costs in inpatient and Part B drugs, especially oncology, over the past 15–18 months.

• 2026 guidance assumes a 7.5% gross and 7% net cost trend, reflecting continued elevated medical costs.

• Contracting discipline led to exiting certain payer arrangements, impacting 50,000 members but improving medical margin by over $125 million year-over-year.

• Administrative cost reductions of $35 million were achieved, with further right-sizing and efficiency initiatives planned.

• Cash position improved, with a projected $125 million balance at end of 2026 and renewed credit facility for added flexibility.

Strategic initiatives and operational improvements

• Enhanced data pipeline launched in Q1 2025, now covers 85% of members, enabling member-level risk scoring and improved cost analysis.

• Clinical programs, notably heart failure (network-wide by 2025), COPD, and dementia (rolling out in 2026), aim to improve outcomes and reduce acute care costs.

• Burden of illness and risk adjustment initiatives expected to deliver a 40 basis point lift in RAF scores for 2026.

• High physician and member retention rates (95% and 90%+ respectively) support stability and consistent care delivery.

• Ongoing use of AI and operational efficiencies targeted for further cost savings in 2026 and 2027.

Industry outlook and payer relationships

• Medicare Advantage (MA) enrollment growth is slowing, but long-term demographic trends support continued expansion.

• Payer partnerships remain constructive, with increased quality incentive dollars and improved data sharing.

• ACO REACH program success positions the company well for the upcoming 10-year LEAD program.

• Contracting approach remains focused on economic returns, with further portfolio refinement expected in 2027.

• CEO search is ongoing, with both internal and external candidates under consideration.